Sign In
Buy OSUR
$4.00
-0.0500 (-1.23%)
At Close: Aug 10, 2026
OraSure Technologies, Inc. (OSUR) Q4 2025 Earnings Call Transcript
08:17pm, Wednesday, 25'th Feb 2026
OraSure Technologies, Inc. (OSUR) Q4 2025 Earnings Call Transcript
Agape ATP (NASDAQ:ATPC) vs. OraSure Technologies (NASDAQ:OSUR) Head to Head Survey
03:03am, Friday, 20'th Feb 2026
OraSure Technologies (NASDAQ: OSUR - Get Free Report) and Agape ATP (NASDAQ: ATPC - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two
OraSure to Launch OraQuick™ HIV Self-Test in Canada
08:05am, Tuesday, 10'th Feb 2026
BETHLEHEM, Pa., Feb. 10, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today
OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th
04:15pm, Monday, 09'th Feb 2026
BETHLEHEM, Pa., Feb. 09, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering fourth quarter 2025 financial results and certai
OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital
01:00pm, Thursday, 15'th Jan 2026
BETHLEHEM, Pa., Jan. 15, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure” and “OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management sol
Altai Capital Management Nominates Two Highly-Qualified Candidates for Election to OraSure Board of Directors
08:30am, Thursday, 15'th Jan 2026
LOS ANGELES--(BUSINESS WIRE)--Altai Capital Management, L.P. ("Altai"), one of the largest shareholders and beneficial owners of approximately 5.2% of the outstanding common stock of OraSure Technolog
OraSure Files for FDA Review of Molecular Self-Test & Colli-Pee Device
12:41pm, Tuesday, 06'th Jan 2026
OSUR files FDA applications seeking approval for two at-home STI tests, advancing decentralized diagnostics; shares gain 3.8% as it targets long-term growth.
OraSure Technologies Issues Statement Regarding Altai Capital's Intent to Nominate Director Candidates
01:23pm, Wednesday, 17'th Dec 2025
BETHLEHEM, Pa., Dec. 17, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure” and “OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management sol
Altai Capital Management Announces Intention to Nominate Two Highly-Qualified Candidates for Election to OraSure Board of Directors
08:00am, Wednesday, 17'th Dec 2025
LOS ANGELES--(BUSINESS WIRE)--Altai Capital Management, L.P. (“Altai”), one of the largest shareholders and beneficial owners of approximately 5.2% of the outstanding common stock of OraSure Techn
OraSure Technologies, Inc. (OSUR) Q3 2025 Earnings Call Transcript
08:11pm, Wednesday, 05'th Nov 2025
OraSure Technologies, Inc. ( OSUR ) Q3 2025 Earnings Call November 5, 2025 5:00 PM EST Company Participants Jason Plagman - Vice President of Investor Relations Carrie Eglinton Manner - President, CEO
OraSure Technologies (OSUR) Reports Q3 Loss, Lags Revenue Estimates
07:51pm, Wednesday, 05'th Nov 2025
OraSure Technologies (OSUR) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to a loss of $0.01 per share a year ago.
OraSure to Announce Third Quarter 2025 Financial Results and Host Earnings Call on November 5th
07:30am, Wednesday, 29'th Oct 2025
BETHLEHEM, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering third quarter 2025 financial results and certain
OraSure Technologies Appoints Steven K. Boyd to its Board of Directors
04:22pm, Tuesday, 28'th Oct 2025
Seasoned Investor with Deep Experience in the Healthcare and Medical Device Industries Brings Valuable Capital Markets Expertise and Investor Perspective OraSure Board Has Added Three New Independen
Exclusive: Altai Capital lays groundwork for board fight at OraSure Technologies, sources say
06:19am, Tuesday, 09'th Sep 2025
Altai Capital Management is preparing to launch a board fight at OraSure Technologies after the hedge fund, already one of the biggest owners of the medical device maker, increased its holdings, two p
Exclusive: Healthcare entrepreneur's letter threatens 'adversarial path' after OraSure Tech rebuffs bid
12:12pm, Monday, 25'th Aug 2025
Prominent healthcare entrepreneur Ron Zwanziger warned on Monday he may pursue a more "adversarial path" if the OraSure Technologies board continues to resist his offer to buy the medical devices comp
